Saol Therapeutics - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

Saol Therapeutics M&A Summary

Saol Therapeutics has acquired 1 company of its own. It has also divested 1 asset.

Saol Therapeutics’ largest acquisition to date was in 2017, when it acquired Aptevo Therapeutics - Hyperimmune Commercial Products for $75M. Saol Therapeutics has acquired in 1 US state. The Company’s most targeted sectors include medical products (100%).

Saol Therapeutics Ownership

Who owns Saol Therapeutics?

Saol Therapeutics is owned by Avego Healthcare Capital and DFW Capital Partners. It was acquired on January 2, 2017.

Is Saol Therapeutics PE-backed?

Yes. Saol Therapeutics is owned by private equity investors Avego Healthcare Capital and DFW Capital Partners.

Saol Therapeutics Business Overview

Where is Saol Therapeutics headquartered?

Saol Therapeutics is headquartered in Roswell, Georgia.

What sector is Saol Therapeutics in?

Saol Therapeutics is a life science company.

When was Saol Therapeutics founded?

Saol Therapeutics was founded in 2015.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity1
    • M&A Sell Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1

Saol Therapeutics

Saol Therapeutics

1000 Holcomb Woods Parkway Suite 270,
Roswell, Georgia 30076
United States,
www.saolrx.com

Saol Therapeutics is a privately held specialty pharmaceutical company focused on providing therapies to patients with rare diseases. Saol Therapeutics has a strategic emphasis on the neurology therapeutic area. Saol Therapeutics was founded in 2015 and is based in Roswell, Georgia.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 1 - - - - - 1
vol $75M $75M
Sell (0.2/yr) # - - - 1 - - 1
  2

Most Recent M&A

Company Date Value Type
Saol Therapeutics - Baclofen Franchise 2022-01-06 - Divestiture
Roswell, Georgia
Aptevo Therapeutics, Inc. - Hyperimmune Commercial Products 2017-08-31 75M USD Divestiture
Seattle, Washington
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Medical Products 1 (100%) 75M (100%) - -
Life Science - - 1 (100%) -
Total 1 $75M 1 -

By Geo

State/Country Buy Value Sell Value
United States 1 75M 1 -
  Washington 1 75M - -
  Georgia - - 1 -
Total 1 $75M 1 -

Deal Values

buy # Total
< $100M 1 $75M
TOTAL $75M
Largest Aptevo Therapeutics, Inc. - Hyperimmune Commercial Products
$75M (2017-08-31)

M&A Connections

Deals
Acquired from
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 209,130
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.